Journal Article
Clinical significance of concomitant bacteriuria in patients with Staphylococcus aureus bacteraemia
Matthaios Papadimitriou-Olivgeris; Damien Jacot; Laurence Senn; Benoit Guery
European Journal of Clinical Microbiology & Infectious Diseases · Vol. 42, Issue 3 · pp. 379-382 · 2023
Abstract
This retrospective study, conducted at Lausanne University Hospital (2015–2021), compared Staphylococcus aureus bacteraemia (SABA) patients with or without concomitant bacteriuria (SABU). Among 448 included bacteraemic patients, 62 (13.8%) had S. aureus concurrently isolated from urine. In multivariate analysis, there was a significant difference in the odds of community-onset bacteraemia ( P 0.030), malignancy ( P 0.002), > 1 pair of positive blood cultures ( P 0.037), and persistent bacteraemia for at least 48 h ( P 0.045) in patients with concurrent SABU. No difference concerning mortality was found. On the other hand, SABU was associated with higher rates of SABA recurrence after antibiotic cessation.